Top Message

New initiatives, advances in clinical study
proposes innovations in clinical trials,
post-marketing surveillance,
post-marketing clinical trials, and PV models.
“Trial GATE”

EPS Corporation will contribute to a healthy and fulfilling life through pharmaceutical development.
We will strive to carry out our mission by delivering the medicines for patients in need even one day earlier.

“Advanced expertise and technology in pharmaceutical development”
“Capabilities to utilize evolving ICT technologies”
“Ability to link the above capabilities and draw a new grand design”

We will continue to be “Trial GATE” that contributes to new initiatives, advances in clinical study, and propose innovations in clinical trials, post-marketing surveillance (PMS), post-marketing clinical trials, and pharmacovigilance (PV) models.

Akira Sasa
President and Representative Director, EPS Corporation